![](https://wcmassets.kbc.be/content/dam/kbc-securities/biography-hero/Thomas-Vranken-kdl-hero.jpg/_jcr_content/renditions/cq5dam.web.680.9999.jpeg.cdn.res/last-modified/1673938002737/cq5dam.web.680.9999.jpeg)
Thomas Vranken
Financial Analyst (Pharma & Biotech)
Email: thomas.vranken@kbcsecurities.be
Phone: +3224172554
Thomas Vranken holds a MSc in Bioscience Engineering from KU Leuven, complemented with a Specialized Masters business degree from ESCP Europe focusing on biopharmaceutical management.
He gained international experience in strategy and M&A analysis with positions at Alira Health and Bayer, and assessed early-stage investment opportunities for life sciences at Gimv. Thomas joined KBCS in 2021 from Roland Berger, where he worked as a strategy consultant focusing on investor support.